Tertomotide Completed Phase 2 Trials for Hepatocellular Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00444782A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.